Targeted Treatment Plus Tislelizumab and HAIC for Advanced CRCLM Failed From Standard Systemic Treatment

Clinical trial NCT06199232 · COMPLETED

Trial details

NCT number: NCT06199232
Sponsor: Peking University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Liver Metastasis Colon Cancer ctDNA Genotype MSS Failed From Standard Treatment

Start date: 2024-01-23
Primary completion: 2026-07-10
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.